Director McBrady to exit Axon (NASDAQ: AXON) board at 2026 meeting

Rhea-AI Filing Summary

Axon Enterprise, Inc. reports that director Matthew McBrady has informed the Board that he will not stand for re-election at the Company’s 2026 Annual Meeting of Shareholders. He will continue serving as a director until his term expires at the meeting.

The Company states that Mr. McBrady’s decision is not due to any disagreement with Axon regarding its operations, policies, or practices. The Board expresses appreciation for his commitment, leadership, and contributions to the Company’s growth during his years of service.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Terms

Board of Directors, Annual Meeting of Shareholders, Emerging growth company

3 terms

Board of Directors financial

"notified the Board of Directors (the “Board”) of Axon Enterprise, Inc."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

Annual Meeting of Shareholders financial

"will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Emerging growth company financial

"Emerging growth company o o Item 5.02 Departure of Directors"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Understanding 8-K Material Events →

0001069183FALSE00010691832026-04-062026-04-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________________

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

April 6, 2026

Date of Report (Date of earliest event reported)

________________________________________________________

Axon Enterprise, Inc.

(Exact name of registrant as specified in its charter)

Delaware			001-16391			86-0741227
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

17800 N. 85th St.

Scottsdale, Arizona 85255

(Address of principal executive offices, including zip code)

(480) 991-0797

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.00001 Par Value			AXON			The NASDAQ Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 6, 2026, Matthew McBrady notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that he will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Mr. McBrady will continue to serve as a director until his term expires at the Annual Meeting. Mr. McBrady’s decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

The Board greatly appreciates Mr. McBrady’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during his years of service.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 10, 2026			Axon Enterprise, Inc.
			By:			/s/ ISAIAH FIELDS
						Isaiah Fields Chief Legal Officer and Corporate Secretary

FAQ

What board change did Axon (AXON) disclose in this 8-K filing?

Axon disclosed that director Matthew McBrady will not stand for re-election at the 2026 Annual Meeting. He will remain on the Board until his term expires, and the company emphasizes appreciation for his leadership and contributions over his years of service.

Did Axon (AXON) report any disagreement behind director McBrady’s decision?

Axon states that Mr. McBrady’s decision not to stand for re-election was not the result of any disagreement with the company. This includes no disagreements over Axon’s operations, policies, or practices, suggesting an orderly and amicable transition from the Board.

How long will Matthew McBrady continue serving on Axon’s (AXON) board?

Matthew McBrady will continue to serve as an Axon director until his current term expires at the 2026 Annual Meeting of Shareholders. This allows continuity on the Board while the company prepares for his planned departure and any related succession decisions.

What is the main purpose of this Axon (AXON) Form 8-K filing?

The filing informs investors that director Matthew McBrady will not seek re-election at the 2026 Annual Meeting and confirms there is no underlying disagreement with the company. It provides transparency about upcoming Board changes and affirms continuity until the meeting.

Who signed the Axon (AXON) 8-K regarding director McBrady’s plans?

The 8-K is signed on behalf of Axon Enterprise, Inc. by Isaiah Fields, the company’s Chief Legal Officer and Corporate Secretary. His signature indicates the disclosure is an authorized corporate communication regarding the planned Board transition.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.3 KB